FDA Inspection
U.S. Continental Marketing, Inc.FDA Inspection 1175769 - U.S. Continental Marketing, Inc. - July 21, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns U.S. Continental Marketing, Inc., with an inspection on July 21, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · 76d0784f-cad7-4f1a-8eb4-6b7b23f7b05e
Violation Codes5
21 CFR 211.125(a)21 CFR 211.22(d)21 CFR 211.25(a)21 CFR 211.6321 CFR 211.67(b)
Full citation text and observation details available on the Dashboard.